Fidelity Investments
RCEL icon

Fidelity Investments’s Avita Medical RCEL Stock Holding History

Fidelity Investments’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$134K Buy
32,515
+3,879
+14% +$16.7K ﹤0.01% 3844
2026
Q1 		$106K Buy
28,636
+25,981
+979% +$109K ﹤0.01% 3771
2025
Q4 		$9.16K Sell
2,655
-185
-7% -$738 ﹤0.01% 4764
2025
Q3 		$14.5K Sell
2,840
-1,746
-38% -$9.11K ﹤0.01% 4486
2025
Q2 		$24.3K Sell
4,586
-723
-14% -$5.26K ﹤0.01% 4219
2025
Q1 		$43.2K Buy
5,309
+712
+15% +$6.65K ﹤0.01% 3914
2024
Q4 		$58.8K Buy
4,597
+349
+8% +$4.12K ﹤0.01% 3771
2024
Q3 		$45.5K Buy
4,248
+2,376
+127% +$22.3K ﹤0.01% 3820
2024
Q2 		$14.8K Buy
1,872
+1,146
+158% +$10.9K ﹤0.01% 4184
2024
Q1 		$11.6K Buy
726
+143
+25% +$2.31K ﹤0.01% 4218
2023
Q4 		$8K Sell
583
-300
-34% -$3.44K ﹤0.01% 4303
2023
Q3 		$12.9K Buy
883
+648
+276% +$11K ﹤0.01% 4005
2023
Q2 		$4K Hold
235
– – ﹤0.01% 4427
2023
Q1 		$3.28K Buy
235
+8
+4% +$85 ﹤0.01% 4499
2022
Q4 		$1.5K Sell
227
-442
-66% -$2.65K ﹤0.01% 4579
2022
Q3 		$3K Sell
669
-1,080
-62% -$6.67K ﹤0.01% 4486
2022
Q2 		$8K Buy
1,749
+995
+132% +$6.15K ﹤0.01% 4183
2022
Q1 		$6K Buy
+754
New +$6.95K ﹤0.01% 4393
2021
Q4 		– Sell
-1
Closed – – 4832
2021
Q3 		$0 Sell
1
-1
-50% -$19 ﹤0.01% 4911
2021
Q2 		$0 Hold
2
– – ﹤0.01% 4762
2021
Q1 		$0 Buy
+2
New +$47 ﹤0.01% 4443

Other funds holding RCEL

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments's RCEL Position: Q2 2026 in Review

Fidelity Investments increased its Avita Medical (RCEL) stake by 14% in Q2 2026, buying an estimated $16.7K and bringing the position to 32,515 shares worth $134K. The position accounts for ﹤0.01% of the portfolio, ranked #3844.

Fidelity Investments first reported a position in RCEL in Q1 2021 and has held it in 21 quarters since. 73 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • Fidelity Investments held 32,515 shares of Avita Medical worth $134K as of Q2 2026.
  • Fidelity Investments bought 3,879 Avita Medical shares in Q2 2026, an estimated $16.7K.
  • Avita Medical made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #3844 holding.
  • Fidelity Investments first reported a position in Avita Medical in Q1 2021 and has held it in 21 quarters since.
  • 73 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.